LEADER 02231nam 2200397 450 001 9910138009103321 005 20230226080116.0 035 $a(CKB)3230000000015863 035 $a(NjHacI)993230000000015863 035 $a(EXLCZ)993230000000015863 100 $a20230226d1992 uy 0 101 0 $afre 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 12$aL'alle?gement de la dette au Club de Paris $eLes e?volutions re?centes en perspective /$fAnn Vourc'h 210 1$aParis, France :$cOECD Publishing,$d1992. 215 $a1 online resource (57 pages) $cillustrations 225 0 $aOECD Development Centre Working Papers 330 $aWhat does the Paris Club do for debtor countries, and more particularly for the poorest of them? Set up to ease the liquidity constraints of a country experiencing payment problems, by rescheduling its debt with the creditor governments, the Paris Club has frequently had to intervene since the beginning of the debt crisis. Since the Toronto Summit of June 1988 it has also been playing the role of aid provider for the poorest debtor countries. After describing the functioning of the Paris Club in part one, the study goes on to evaluate the extent and role of the liquidity provided by the Club throughout the 1980s in part two. An initial finding is that the sums rescheduled through its action were very much greater than those lent over the same period by the creditor governments comprising the Club. Through focusing on selected African countries, the paper then shows that the main role of the liquidity created has been to avoid these countries' accumulating massive arrears and being cut. 517 $aL'allégement de la dette au Club de Paris 606 $aDebt relief 606 $aDebt relief$zDeveloping countries 607 $aFrance$zParis 607 $aDeveloping Countries 615 0$aDebt relief. 615 0$aDebt relief 676 $a332.02402 700 $aVourc'h$b Ann$01287161 801 0$bNjHacI 801 1$bNjHacl 906 $aDOCUMENT 912 $a9910138009103321 996 $aL'alle?gement de la dette au Club de Paris$93035926 997 $aUNINA LEADER 02971nam 22005774a 450 001 9910830085003321 005 20230721033134.0 010 $a1-281-93868-8 010 $a9786611938680 010 $a0-470-40910-X 010 $a0-470-40905-3 035 $a(CKB)1000000000551811 035 $a(EBL)380501 035 $a(OCoLC)437241459 035 $a(SSID)ssj0000212701 035 $a(PQKBManifestationID)11173616 035 $a(PQKBTitleCode)TC0000212701 035 $a(PQKBWorkID)10138878 035 $a(PQKB)10551139 035 $a(MiAaPQ)EBC380501 035 $a(EXLCZ)991000000000551811 100 $a20080703d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aNuclear receptors in drug metabolism$b[electronic resource] /$fedited by Wen Xie 210 $aHoboken, NJ $cJohn Wiley & Sons$dc2009 215 $a1 online resource (362 p.) 300 $aDescription based upon print version of record. 311 $a0-470-08679-3 320 $aIncludes bibliographical references and index. 327 $aDrug metabolism : significance and challenges -- Establishing orphan nuclear receptors PXR and CAR as xenobiotic receptors -- Nuclear receptor-mediated regulation of phase II conjugating enzymes -- Nuclear receptor-mediated regulation of drug transporters -- Structure and function of PXR and CAR -- Xenobiotic receptor cofactors and coregulators -- Animal models of xenobiotic nuclear receptors and their utility in drug development -- Nuclear receptors and drug-drug interactions of prescription drugs and herbal medicines -- Genetic variants of xenobiotic receptors and their implications in drug metabolism and pharmacogenetics -- Beyond PXR and CAR, regulation of xenobiotic metabolism by other nuclear receptors -- Emerging role of retinoid-related orphan receptor (ROR) and its cross talk with LXR (liver X receptor) in the regulation of drug-metabolizing enzymes. 330 $aThis book gives you an updated and expert overview of nuclear hormone receptors in drug metabolism and drug development and equips you with the interdisciplinary understanding of these receptors and how they can be regulated. Pharmaceutical researchers will find this extremely useful in developing drugs for cancer, heart disease, and diabetes treatment. This comprehensive resource collects scattered materials into one handy, informative volume. 606 $aDrugs$xMetabolism 606 $aNuclear receptors (Biochemistry) 606 $aGenetic regulation 615 0$aDrugs$xMetabolism. 615 0$aNuclear receptors (Biochemistry) 615 0$aGenetic regulation. 676 $a615.19 676 $a615/.7 701 $aXie$b Wen$f1967-$01672776 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910830085003321 996 $aNuclear receptors in drug metabolism$94036335 997 $aUNINA